Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.

Laplaud DA, Casey R, Barbin L, Debouverie M, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Lubetzki C, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Wahab A, Labauge P, Magy L, Defer G, Guennoc AM, Maubeuge N, Labeyrie C, Patry I, Nifle C, Casez O, Michel L, Rollot F, Leray E, Vukusic S, Foucher Y; SFSEP and OFSEP groups.

Neurology. 2019 Aug 13;93(7):e635-e646. doi: 10.1212/WNL.0000000000007938. Epub 2019 Jul 12.

PMID:
31300547
2.

Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS.

Lavie C, Rollot F, Durand-Dubief F, Marignier R, Ionescu I, Casey R, Moreau T, Tourniaire P, Hutchinson M, D'Hooghe MB, Laplaud DA, Clavelou P, De Sèze J, Debouverie M, Brassat D, Pelletier J, Lebrun-Frenay C, Le Page E, Castelnovo G, Berger E, Hautecoeur P, Heinzlef O, Durelli L, Clerico M, Trojano M, Patti F, Vukusic S; PRIMS and POPARTMUS investigators.

Mult Scler. 2019 Apr;25(4):591-600. doi: 10.1177/1352458518763080. Epub 2018 Mar 20.

PMID:
31081475
3.

Treatment satisfaction and quality of life in patients treated with fingolimod.

Mékiès C, Heinzlef O, Jenny B, Ramelli AL, Clavelou P.

Patient Prefer Adherence. 2018 May 22;12:899-907. doi: 10.2147/PPA.S144021. eCollection 2018.

4.

MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study.

Tourbah A, Gout O, Vighetto A, Deburghgraeve V, Pelletier J, Papeix C, Lebrun-Frenay C, Labauge P, Brassat D, Toosy A, Laplaud DA, Outteryck O, Moreau T, Debouverie M, Clavelou P, Heinzlef O, De Sèze J, Defer G, Sedel F, Arndt C.

CNS Drugs. 2018 Jul;32(7):661-672. doi: 10.1007/s40263-018-0528-2.

5.

Neural mechanisms associated with treatment decision making: An fMRI study.

Abidi M, Bruce J, Le Blanche A, Bruce A, Jarmolowicz DP, Csillik A, Thai NJ, Lim SL, Heinzlef O, de Marco G.

Behav Brain Res. 2018 Sep 3;349:54-62. doi: 10.1016/j.bbr.2018.04.034. Epub 2018 Apr 23.

PMID:
29698695
6.

Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?

Rouzaud C, Hautecoeur P, Donze C, Heinzlef O, Dinh A; Club Francophone de la Sclérose en Plaque, Creange A, Abdullatif A, Audouin B, Tourbah A, Berger E, Bourre B, Brochet B, Mekies C, Cabre P, Papeix C, Casez O, Brassat D, Defer G, Derache N, De Seze J, Dive D, LePage E, Fromont A, Gouider R, Edan G, Pelletier J, Grimaud J, Guennoc AM, Camdessanché JP, Kwiatkowski A, Laplaud D, Lebrun C, Debouverie M, Coustans M, Gout O, La Rochelle OA, Heinzlef O, Ouallet JC, Cavelou P, Hautecoeur P, Labauge P, Vermersch P, Wiertlewski S, Vukusic S, Marignier R, Schluep M, Seeldrayers P, Slassi I, Stankoff B, Thaite F, Moreau T, Thouvenot E, Zephir H, Ciron J, Collongues N, Kerschen P, Cohen M, Gueguen A, Mathey G, Carra C, Bernady P, Faucheux JM, Planque E, Donze C, Ruet A, Mouzawakh C, Pittion S.

Mult Scler Relat Disord. 2017 Nov;18:161-163. doi: 10.1016/j.msard.2017.08.009. Epub 2017 Aug 24. No abstract available.

PMID:
29141801
7.

Anxiety, emotional processing and depression in people with multiple sclerosis.

Gay MC, Bungener C, Thomas S, Vrignaud P, Thomas PW, Baker R, Montel S, Heinzlef O, Papeix C, Assouad R, Montreuil M.

BMC Neurol. 2017 Feb 23;17(1):43. doi: 10.1186/s12883-017-0803-8.

8.

Anxiety and Coping Strategy Changes in Multiple Sclerosis Patients Initiating Fingolimod: The GRACE Prospective Study.

Moreau T, Bungener C, Heinzlef O, Suchet L, Borgel F, Bourdeix I, Meite M, Rerat K, Chouette I; GRACE Study Group.

Eur Neurol. 2017;77(1-2):47-55. doi: 10.1159/000451077. Epub 2016 Dec 2.

PMID:
27907914
9.

Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.

Peyro Saint Paul L, Creveuil C, Heinzlef O, De Seze J, Vermersch P, Castelnovo G, Cabre P, Debouverie M, Brochet B, Dupuy B, Lebiez P, Sartori É, Clavelou P, Brassat D, Lebrun-Frenay C, Daplaud D, Pelletier J, Coman I, Hautecoeur P, Tourbah A, Defer G.

J Neurol Sci. 2016 Apr 15;363:69-76. doi: 10.1016/j.jns.2016.02.012. Epub 2016 Feb 6.

PMID:
27000224
10.

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Barbin L, Rousseau C, Jousset N, Casey R, Debouverie M, Vukusic S, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Créange A, Labauge P, Magy L, Defer G, Foucher Y, Laplaud DA; CFSEP and OFSEP groups.

Neurology. 2016 Feb 23;86(8):771-8. doi: 10.1212/WNL.0000000000002395. Epub 2016 Jan 29.

11.

Expert patients living with multiple sclerosis: description of a training device

Perreira Paulo L, Rébillon M, Furic B, Heinzlef O.

Rev Prat. 2015 Nov;65(9):1222-1224. French. No abstract available.

PMID:
30512519
12.

[To treat or not to treat asymptomatic bacteriuria before methylprednisolone perfusion].

Donzé C, Dinh A, Heinzlef O, Hautecoeur P.

Rev Neurol (Paris). 2015 Sep;171(8-9):669-73. doi: 10.1016/j.neurol.2015.04.013. Epub 2015 Aug 28. French.

PMID:
26318899
13.

Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.

Ziemssen T, Bajenaru OA, Carrá A, de Klippel N, Correia de Sá J, Edland A, Frederiksen JL, Heinzlef O, Karageorgiou KE, Lander Delgado RH, Landtblom AM, Macías Islas MA, Tubridy N, Gilgun-Sherki Y.

J Neurol. 2015 Jan;262(1):248. doi: 10.1007/s00415-014-7565-7. No abstract available.

14.

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.

Ziemssen T, Bajenaru OA, Carrá A, de Klippel N, de Sá JC, Edland A, Frederiksen JL, Heinzlef O, Karageorgiou KE, Lander Delgado RH, Landtblom AM, Macías Islas MA, Tubridy N, Gilgun-Sherki Y.

J Neurol. 2014 Nov;261(11):2101-11. doi: 10.1007/s00415-014-7446-0. Epub 2014 Aug 14. Erratum in: J Neurol. 2015 Jan;262(1):248.

15.

Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study.

Cohen M, Maillart E, Tourbah A, De Sèze J, Vukusic S, Brassat D, Anne O, Wiertlewski S, Camu W, Courtois S, Ruet A, Debouverie M, Le Page E, Casez O, Heinzlef O, Stankoff B, Bourre B, Castelnovo G, Rico A, Berger E, Camdessanche JP, Defer G, Clavelou P, Al Khedr A, Zephir H, Fromont A, Papeix C, Brochet B, Pelletier J, Lebrun C; Club Francophone de la Sclérose en Plaques Investigators.

JAMA Neurol. 2014 Apr;71(4):436-41. doi: 10.1001/jamaneurol.2013.6240.

PMID:
24566807
16.

[Pharmacological treatment of spasticity in multiple sclerosis].

Heinzlef O, Monteil-Roch I.

Rev Neurol (Paris). 2012 Apr;168 Suppl 3:S62-8. doi: 10.1016/S0035-3787(12)70049-8. Review. French.

PMID:
22721367
17.

Cancer and multiple sclerosis in the era of disease-modifying treatments.

Lebrun C, Vermersch P, Brassat D, Defer G, Rumbach L, Clavelou P, Debouverie M, de Seze J, Wiertlevsky S, Heinzlef O, Tourbah A, Fromont A, Frenay M.

J Neurol. 2011 Jul;258(7):1304-11. doi: 10.1007/s00415-011-5929-9. Epub 2011 Feb 4.

PMID:
21293872
18.

Neuromyelitis optica in France: a multicenter study of 125 patients.

Collongues N, Marignier R, Zéphir H, Papeix C, Blanc F, Ritleng C, Tchikviladzé M, Outteryck O, Vukusic S, Fleury M, Fontaine B, Brassat D, Clanet M, Milh M, Pelletier J, Audoin B, Ruet A, Lebrun-Frenay C, Thouvenot E, Camu W, Debouverie M, Créange A, Moreau T, Labauge P, Castelnovo G, Edan G, Le Page E, Defer G, Barroso B, Heinzlef O, Gout O, Rodriguez D, Wiertlewski S, Laplaud D, Borgel F, Tourniaire P, Grimaud J, Brochet B, Vermersch P, Confavreux C, de Seze J.

Neurology. 2010 Mar 2;74(9):736-42. doi: 10.1212/WNL.0b013e3181d31e35.

PMID:
20194912
19.

Tear analysis in clinically isolated syndrome as new multiple sclerosis criterion.

Calais G, Forzy G, Crinquette C, Mackowiak A, de Seze J, Blanc F, Lebrun C, Heinzlef O, Clavelou P, Moreau T, Hennache B, Zephir H, Verier A, Neuville V, Confavreux C, Vermersch P, Hautecoeur P.

Mult Scler. 2010 Jan;16(1):87-92. doi: 10.1177/1352458509352195. Epub 2009 Dec 22.

PMID:
20028709
20.

[Motor deficit].

Heinzlef O.

Rev Neurol (Paris). 2009 Mar;165 Suppl 4:S163-6. doi: 10.1016/S0035-3787(09)72129-0. Review. French.

PMID:
19361682
21.

A longitudinal observational study of a cohort of patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate.

Debouverie M, Moreau T, Lebrun C, Heinzlef O, Brudon F, Msihid J.

Eur J Neurol. 2007 Nov;14(11):1266-74.

PMID:
17956447
22.

Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies.

Ducray F, Roos-Weil R, Garcia PY, Slesari J, Heinzlef O, Chatelain D, Toussaint P, Roullet E, Honnorat J.

J Neurol Neurosurg Psychiatry. 2007 Mar;78(3):325-7. No abstract available.

23.

[Livedo-like dermatitis (Nicolau's syndrome) after injection of Copolymer-1 (Glatiramer acetate)].

Gaudez C, Regnier S, Aractingi S, Heinzlef O.

Rev Neurol (Paris). 2003 May;159(5 Pt 1):571-3. French.

PMID:
12773903
24.

Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics.

Heinzlef O, Weill B, Johanet C, Sazdovitch V, Caillat-Zucman S, Tournier-Lasserve E, Roullet E.

J Neurol Neurosurg Psychiatry. 2002 May;72(5):647-9.

25.

[Atherosclerotic aortic plaques and risk of embolic stroke].

Heinzlef O, Cohen A, Amarenco P.

Rev Neurol (Paris). 2001 Jul;157(6-7):619-31. Review. French.

PMID:
11458181
26.

Recurrent stroke and vascular events in elderly patients with anticardiolipin antibodies: a prospective study.

Heinzlef O, Abuaf N, Cohen A, Amarenco P; French Study of Aortic Plaques in Stroke Group.

J Neurol. 2001 May;248(5):373-9.

PMID:
11437157
27.

MS and neuromyelitis optica in Martinique (French West Indies).

Cabre P, Heinzlef O, Merle H, Buisson GG, Bera O, Bellance R, Vernant JC, Smadja D.

Neurology. 2001 Feb 27;56(4):507-14.

PMID:
11222796
28.

[Familial multiple sclerosis: study of 357 consecutive patients].

Sazdovitch V, Verdier-Taillefer MH, Heinzlef O, Alamowitch S, Roullet E.

Rev Neurol (Paris). 2000 Jul;156(6-7):638-40. French.

PMID:
10891798
29.

Multiple sclerosis and antecedent infections: a case-control study.

Marrie RA, Wolfson C, Sturkenboom MC, Gout O, Heinzlef O, Roullet E, Abenhaim L.

Neurology. 2000 Jun 27;54(12):2307-10.

PMID:
10881258
30.

Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia.

Fonknechten N, Mavel D, Byrne P, Davoine CS, Cruaud C, Bönsch D, Samson D, Coutinho P, Hutchinson M, McMonagle P, Burgunder JM, Tartaglione A, Heinzlef O, Feki I, Deufel T, Parfrey N, Brice A, Fontaine B, Prud'homme JF, Weissenbach J, Dürr A, Hazan J.

Hum Mol Genet. 2000 Mar 1;9(4):637-44. Erratum in: Hum Mol Genet. 2005 Feb 1;14(3):461. Boentsch, D [corrected to Bönsch, D].

PMID:
10699187
31.

Autoimmune diseases in families of French patients with multiple sclerosis.

Heinzlef O, Alamowitch S, Sazdovitch V, Chillet P, Joutel A, Tournier-Lasserve E, Roullet E.

Acta Neurol Scand. 2000 Jan;101(1):36-40.

PMID:
10660150
32.

[Towards a reliable prognosis for multiple sclerosis].

Heinzlef O, Roullet E.

Rev Prat. 1999 Nov 1;49(17):1872-5. French.

PMID:
10598503
33.

Paradoxical emboli: the proof was short lived.

Heinzlef O, Cormier B, Mayniel D.

J Neurol Neurosurg Psychiatry. 1999 May;66(5):687. No abstract available.

34.

Brain infarction following 5-fluorouracil and cisplatin therapy.

El Amrani M, Heinzlef O, Debroucker T, Roullet E, Bousser MG, Amarenco P.

Neurology. 1998 Sep;51(3):899-901.

PMID:
9748055
35.

Severe neuropathy after high dose carboplatin in three patients receiving multidrug chemotherapy.

Heinzlef O, Lotz JP, Roullet E.

J Neurol Neurosurg Psychiatry. 1998 May;64(5):667-9.

36.

Mapping of a complicated familial spastic paraplegia to locus SPG4 on chromosome 2p.

Heinzlef O, Paternotte C, Mahieux F, Prud'homme JF, Dien J, Madigand M, Pouget J, Weissenbach J, Roullet E, Hazan J.

J Med Genet. 1998 Feb;35(2):89-93.

37.

[Multiple sclerosis. Lessons drawn from familial incidence].

Roullet E, Heinzlef O, Alamowitch S.

Presse Med. 1997 Oct 25;26(32):1539-42. Review. French. No abstract available.

PMID:
9435837
38.

[Gayet-Wernicke encephalopathy and centropontine myelionolysis induced by hyperemesis gravidarum].

Olindo S, Smadja D, Cabre P, Mehdaoui H, Heinzlef O.

Rev Neurol (Paris). 1997 Jul;153(6-7):427-9. French.

PMID:
9684011
39.

[Acute aseptic meningitis after hepatitis B vaccination].

Heinzlef O, Moguilewski A, Roullet E.

Presse Med. 1997 Mar 8;26(7):328. French. No abstract available.

PMID:
9122145
40.

An update on aortic causes of ischemic stroke.

Heinzlef O, Cohen A, Amarenco P.

Curr Opin Neurol. 1997 Feb;10(1):64-72. Review.

PMID:
9099530
41.

[Multiple sclerosis. Epidemiology, diagnosis, course, prognosis].

Heinzlef O, Roullet E.

Rev Prat. 1996 Dec 1;46(19):2373-9. French. No abstract available.

PMID:
8978197
42.

Prevalence of serum antibodies to hepatitis C virus is not increased in patients with multiple sclerosis.

Heinzlef O, Roullet E, Johanet C, Tournier-Lasserve E, Chazouilleres O.

J Neurol Neurosurg Psychiatry. 1996 Dec;61(6):655-6. No abstract available.

43.

[Spontaneous regression of primary cerebral lymphoma].

Heinzlef O, Poisson M, Delattre JY.

Rev Neurol (Paris). 1996 Feb;152(2):135-8. Review. French.

PMID:
8761621
44.

Antinuclear antibodies in multiple sclerosis.

Heinzlef O, Johannet C, Tournier-Lasserve E, Roullet E.

Neurology. 1995 Dec;45(12):2299-300; author reply 2300-1. No abstract available.

PMID:
8848219
45.

[POEMS cured by radical treatment of plasmacytoma].

Mahieux F, Baudrimont M, Fenelon G, Heinzlef O, Bakouche P, Sabourin P, Guillard A.

Rev Neurol (Paris). 1991;147(3):231-3. French.

PMID:
1648253

Supplemental Content

Loading ...
Support Center